Definitive Contract 36C24821C0042
Award Date 7/16/21
Potential Completion Date 7/14/26
Potential Value $594K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bay Pines, FL 33744, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a medical diagnostic company specializing in advanced genomic testing services. The contract is an Indefinite Delivery/Indefinite Quantity (IDIQ) with a ceiling value of $72,800.00 for providing reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. Veracyte will perform these testing...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
- This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....
- This firm fixed price federal contract award was made by the Defense Health Agency (DHA) to Veracyte, Inc., a for-profit corporate entity that provides genomic testing services. The contract is for $116,000.00 and has a period of performance ending on September 30, 2015. The services provided under this contract include analyzing gene expression patterns in biopsy samples to determine malignancy risk, aid in diagnosis and treatment decisions, as well as testing to differentiate idiopathic...
- This federal contract award is for a task order under the NWI VAHCS TASK ORDER VERACYTE REFERENCE LABORATORY SERVICES IDIQ, a $62,000.00 firm fixed-price delivery order contract awarded to Veracyte, Inc., a for-profit medical diagnostic company headquartered in South San Francisco, California. The contract is with the Veterans Integrated Service Network 23 (VISN 23), a civilian agency under the Department of Veterans Affairs, for reference laboratory services. Veracyte will provide specialized...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostic company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the Department of Veterans Affairs (VA). The contract is an Indefinite Delivery, Indefinite Quantity (IDIQ) with a ceiling value of $112,200.00 for reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2026. The contract is not set aside and was awarded on May 1,...
- This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...
- This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command to Veracyte, Inc., a for-profit organization that provides genomic testing services. The contract, valued at $96,176.63, is for the provision of supply/service in support of the agency's cancer detection and diagnosis efforts. Veracyte holds an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with the Veterans Health Administration's Veterans Integrated Service Network 23, valued at up to...
- This federal contract award was issued by the Defense Health Agency to Veracyte, Inc., a for-profit provider of genomic testing services. The $8,600 firm fixed price contract is for GEC PATIENT TESTING services, which involves analyzing gene expression patterns in biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for cancer and other diseases. Veracyte holds an Indefinite Delivery Indefinite Quantity contract vehicle from the Veterans Health...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23) to Veracyte, Inc., a for-profit medical diagnostic company, for reference laboratory services. The contract has a ceiling value of $86,000.00 and a performance period ending on April 30, 2026. Veracyte provides specialized genomic testing services, including the Decipher Prostate Cancer Test, Afirma Genomic Sequencing Classifier, and testing for conditions like idiopathic...